Prepare for your visit

Yeimi Ines Rivera

Nurse Practitioner · Scottsdale, AZ · NPI 1568965952

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$450.51

in general payments reported to CMS, 2019-2025 · $160 in 2025

The $160 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).

Who reported paying

General payments only, top 6 by amount.

Edwards Lifesciences Corporation $161.02
Novartis Pharmaceuticals Corporation $129.08
Merck Sharp & Dohme LLC $61.46
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $24.04
Boehringer Ingelheim Pharmaceuticals, INC. $23.01
E.R. Squibb & Sons, L.L.C. $20.72

Drugs and devices associated with these payments

Leqvio Winrevair Lifevest Jardiance Eliquis Ffrct Attruby

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Yeimi Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11156313/yeimi-ines-rivera